TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Esperion Therapeutics, Inc. (NASDAQ: ESPR) Investor Securities Class Action Lawsuit 05/07/2018

  • If you purchased shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

February 19, 2019 - The case was dismissed. November 13, 2018 - A motion to dismiss the amended complaint was filed. October 22, 2018 - An amended complaint was filed. May 7, 2018 - An investor in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) filed a lawsuit in the U.S. District Court for the Eastern District of Michigan over alleged violations of Federal Securities Laws by ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: